About
IV Tramadol, Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Team (9)
Alexandra MacLean, MD
Chief Executive Officer
Avenue Therapeutics
executive
Curtis Oltmans
Avenue Therapeutics
team_member
David Jin
Interim Chief Financial Officer and Chief Operating Officer
Avenue Therapeutics
executive
Faith Charles
Avenue Therapeutics
team_member
Jay Kranzler, MD, PhD
Chairman of the Board of Directors
Avenue Therapeutics
board_chair
Lindsay A. Rosenwald, MD
Avenue Therapeutics
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
1,020
By Phase
PHASE3: 3
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03774836Lead Sponsor
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
PHASE3Active, not recruiting
360 participants
Started: Dec 14, 2018 · Completed: Jun 30, 2019
NCT03395808Lead Sponsor
Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery
PHASE3Completed
251 participants
Started: Dec 22, 2017 · Completed: May 6, 2019
NCT03290378Lead Sponsor
Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
PHASE3Completed
409 participants
Started: Sep 19, 2017 · Completed: Apr 23, 2018
Locations (1)
Headquarters
Bay Harbor Islands, FL, United States
Map
Loading map...